Patents by Inventor Denise M. O'Hara

Denise M. O'Hara has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS COMPRISING PLANT EXTRACTS AND OILS AND RELATED METHODS OF TREATMENT AND THEIR PREPARATION
    Publication number: 20220233627
    Abstract: Disclosed are compositions comprising botanical extracts and cold-pressed oils and related methods of manufacture and methods of use for the treatment of skin conditions and diseases.
    Type: Application
    Filed: May 13, 2020
    Publication date: July 28, 2022
    Inventors: Denise M. O'Hara, Mengmeng Wang
  • Anti-ED-A immunoconjugates for inflammatory bowel disease
    Patent number: 10239939
    Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: March 26, 2019
    Assignee: PHILOGEN S.P.A.
    Inventors: Giovanni Neri, Kathrin Schwager, Melanie C. Ruzek, Denise M. O'hara, Jianqing Chen
  • ANTIGENS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Publication number: 20180044408
    Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
    Type: Application
    Filed: June 1, 2017
    Publication date: February 15, 2018
    Inventors: Giovanni Neri, Kathrin Schwager, Melanie C. Ruzek, Denise M. O'hara, Jianqing Chen
  • Anti-ED-A immunoconjugates for inflammatory bowel disease
    Patent number: 9695232
    Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
    Type: Grant
    Filed: October 3, 2012
    Date of Patent: July 4, 2017
    Assignee: Philogen S.p.A.
    Inventors: Giovanni Neri, Kathrin Schwager, Melanie C. Ruzek, Denise M. O'Hara, Jianqing Chen
  • PHYSIOLOGICALLY-RELEVANT AFFINITY MEASUREMENTS IN VITRO WITH BACKSCATTERING INTERFEROMETRY
    Publication number: 20170067882
    Abstract: Disclosed herein are improved optical detection methods comprising interferometric detection systems and methods of detecting a binding interaction between a sample comprising uncultured tissue homogenate and an analyte, together with various applications of the disclosed techniques. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: February 20, 2015
    Publication date: March 9, 2017
    Inventors: Darryl J. BORNHOP, Amanda KUSSROW, Denise M. O'HARA, Mengmeng WANG
  • ANTIGENS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Publication number: 20150361161
    Abstract: Specific binding members that bind the ED-A isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (IBD), and/or for use in delivery to the IBD tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, such as interleukin-10.
    Type: Application
    Filed: October 3, 2012
    Publication date: December 17, 2015
    Inventors: Giovanni Neri, Kathrin Schwager, Melanie C. Ruzek, Denise M. O'Hara, Jianqing Chen